Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Heliyon ; 10(7): e28576, 2024 Apr 15.
Artículo en Inglés | MEDLINE | ID: mdl-38586403

RESUMEN

While economic growth and food security in Vietnam's Red River Delta are heavily reliant on agriculture, the intensive use of agricultural land has resulted in various negative impacts on the environment, such as soil degradation, water pollution, biodiversity loss, and health effects on humans and animals. The current situation emphasizes an increased need for sustainable agriculture practices in the region. Understanding farmers' decision-making processes and identifying factors that influence their choices is crucial in order to promote their adoption of sustainable agriculture practices. This study examines the impact of attitudes, subjective norms, perceived behavioral control, age, and gender on farmers' intention to adopt sustainable agriculture practices using the Theory of Planned Behavior and Partial Least Squares Structural Equation Modeling. The results show that attitude towards sustainable agriculture practices showed a path coefficient of 0.310 (p < 0.001), and perceived behavioral control had a coefficient of 0.305 (p < 0.001), indicating strong positive relationships with intention. However, subjective norms, despite a positive coefficient, did not significantly affect intentions (path coefficient 0.099, p > 0.05). Age was found to have a moderating effect; older farmers are less likely to adopt sustainable agriculture practices compared to their younger counterparts. Gender, however, did not present a significant influence. In light of these findings, policymakers face a challenge in creating incentives to encourage farmers' engagement in sustainable agriculture practices in the Red River Delta and at the same time discourage youth out-migration from the agricultural sector more generally. Overall, this study enriches our theoretical understanding of the factors influencing sustainable agriculture adoption in developing countries and offers practical insights for policymakers and agricultural stakeholders in the Red River Delta to promote more effective and targeted sustainable agriculture practices.

2.
Mol Cancer Res ; 19(8): 1338-1349, 2021 08.
Artículo en Inglés | MEDLINE | ID: mdl-33811160

RESUMEN

Epigenetic regulators can modulate the effects of cancer therapeutics. To further these observations, we discovered that the bromodomain PHD finger transcription factor subunit (BPTF) of the nucleosome remodeling factor (NURF) promotes resistance to doxorubicin, etoposide, and paclitaxel in the 4T1 breast tumor cell line. BPTF functions in promoting resistance to doxorubicin and etoposide, but not paclitaxel, and may be selective to cancer cells, as a similar effect was not observed in embryonic stem cells. Sensitization to doxorubicin and etoposide with BPTF knockdown (KD) was associated with increased DNA damage, topoisomerase II (TOP2) crosslinking and autophagy; however, there was only a modest increase in apoptosis and no increase in senescence. Sensitization to doxorubicin was confirmed in vivo with the syngeneic 4T1 breast tumor model using both genetic and pharmacologic inhibition of BPTF. The effects of BPTF inhibition in vivo are autophagy dependent, based on genetic autophagy inhibition. Finally, treatment of 4T1, 66cl4, 4T07, MDA-MB-231, but not ER-positive 67NR and MCF7 breast cancer cells with the selective BPTF bromodomain inhibitor, AU1, recapitulates genetic BPTF inhibition, including in vitro sensitization to doxorubicin, increased TOP2-DNA crosslinks and DNA damage. Taken together, these studies demonstrate that BPTF provides resistance to the antitumor activity of TOP2 poisons, preventing the resolution of TOP2 crosslinking and associated autophagy. These studies suggest that BPTF can be targeted with small-molecule inhibitors to enhance the effectiveness of TOP2-targeted cancer chemotherapeutic drugs. IMPLICATIONS: These studies suggest NURF can be inhibited pharmacologically as a viable strategy to improve chemotherapy effectiveness.


Asunto(s)
Autofagia/genética , ADN-Topoisomerasas de Tipo II/genética , Nucleosomas/genética , Neoplasias de la Mama Triple Negativas/genética , Animales , Antígenos Nucleares/genética , Antineoplásicos/farmacología , Apoptosis/efectos de los fármacos , Apoptosis/genética , Autofagia/efectos de los fármacos , Línea Celular , Línea Celular Tumoral , Doxorrubicina/farmacología , Femenino , Células HEK293 , Humanos , Células MCF-7 , Ratones , Ratones Endogámicos BALB C , Proteínas del Tejido Nervioso/genética , Factores de Transcripción/genética , Neoplasias de la Mama Triple Negativas/tratamiento farmacológico
3.
J Biol Chem ; 2018 Aug 23.
Artículo en Inglés | MEDLINE | ID: mdl-30139747

RESUMEN

This article has been withdrawn by Aiman Alhazmi, Marissa Mack, Tiffany Rolle, Jordan Hiegel, Syed Haqqani, Nga Dao, Farheen Zaman, Nak-Kyeong Kim, Neel Scarsdale, Charles Lyons, and Joseph Landry. Some of the genome-wide data sets were flawed and were not analyzed correctly. The withdrawing authors are in the process of correcting the data sets and re-analyzing them for resubmission.

4.
Adv Cancer Res ; 138: 1-39, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-29551125

RESUMEN

Cancer chemotherapeutic drugs have greatly advanced our ability to successfully treat a variety of human malignancies. The different forms of stress produced by these agents in cancer cells result in both cell autonomous and cell nonautonomous effects. Desirable cell autonomous effects include reduced proliferative potential, cellular senescence, and cell death. More recently recognized cell nonautonomous effects, usually in the form of stimulating an antitumor immune response, have significant roles in therapeutic efficiency for a select number of chemotherapies. Unfortunately, the success of these therapeutics is not universal as not all tumors respond to treatment, and those that do respond will frequently relapse into therapy-resistant disease. Numerous strategies have been developed to sensitize tumors toward chemotherapies as a means to either improve initial responses, or serve as a secondary treatment strategy for therapy-resistant disease. Recently, targeting epigenetic regulators has emerged as a viable method of sensitizing tumors to the effects of chemotherapies, many of which are cytotoxic. In this review, we summarize these strategies and propose a path for future progress.


Asunto(s)
Antineoplásicos/uso terapéutico , Metilación de ADN , Epigénesis Genética/efectos de los fármacos , Regulación Neoplásica de la Expresión Génica/efectos de los fármacos , Neoplasias/inmunología , Animales , Humanos , Neoplasias/tratamiento farmacológico , Neoplasias/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...